Term
-Inotropic Drugs
-Increases the Ca levels in the heart muscle- Increases contractility- Increases CO- Increases renal blood flow-Increases renin production- Prevents activation of the reninangiotensin system- Increases urine output- Increases BV- Increases heart's workload. |
|
Definition
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype:_____ |
|
Definition
Digoxin (Lanoxin) "Dig"
*originally derived from the foxglove plant. |
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype: Digoxin (Lanoxin) "Dig"
Indications (2): |
|
Definition
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype: Digoxin (Lanoxin) "Dig"
Actions (2): |
|
Definition
- Positive Inotrope, Negative Chronotrope, Negative Dromotrope
- Diuretic Effect (NOT a diuretic)
|
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype: Digoxin (Lanoxin) "Dig"
Adverse Effects (7): |
|
Definition
- Hypotension
- Bradycardia
- Weakness & drowsiness
- Headache
- Vision changes (yellow halo, blurring, spots/threads)
- arrhythmias
- GI Upset
|
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype: Digoxin (Lanoxin) "Dig"
Normal therapeutic dose: |
|
Definition
0.125mg-0.25mg
*Very close to toxic dose |
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype: Digoxin (Lanoxin) "Dig"
Nursing Interventions (1): |
|
Definition
- Monitor for S/E, PG/Lactation, MI
|
|
|
Term
Cardiotonic Agents:
Cardiac Glycosides
Prototype: Digoxin (Lanoxin) "Dig"
Apical pulse for 1 min, if HR is __, hold, reuptake pulse.
1hr later, if still __, hold & notify physician: Document, as this may be an indicator of "dig" toxicity. |
|
Definition
|
|
Term
Cardiotonic Agents:
Digoxin Antidote
Prototype: ___ |
|
Definition
Digoxin Immne Fab (Digibind) |
|
|
Term
____: Stays in system a long time (6-8days). Doses can "build up" on each other & causes too high of a level & remember: therapeutic dose is close to toxic dose. |
|
Definition
|
|
Term
Cardiotonic Agents:
Digoxin Antidote
Prototype: Digoxin Immune Fab (Digibind)
Normal Value Range: |
|
Definition
|
|
Term
Cardiotonic Agents:
Digoxin Antidote
Prototype: Digoxin Immune Fab (Digibind)
Indications (3): Dig Toxicity: |
|
Definition
Dig Toxicity
- >10 ng/mL & symptomatic
- K >5 mEq/L
- Digoxin toxicity s&s: acute- N/V/D & lethargy/ Chronic- S/E of digoxin
|
|
|
Term
Cardiotonic Agents:
Digoxin Antidote
Prototype: Digoxin Immune Fab (Digibind)
Action (1): |
|
Definition
- Binds molecules of digoxin, making them unavailable @ their receptor site. It's an antibody found in sheep.
|
|
|
Term
Cardiotonic Agents:
Digoxin Antidote
Prototype: Digoxin Immune Fab (Digibind)
Adverse Effects (3): |
|
Definition
- Allergic response to drug
- Reemergence of HF & AFib
- Hypokalemia
|
|
|
Term
Cardiotonic Agents:
Digoxin Antidote
Prototype: Digoxin Immune Fab (Digibind)
Nursing Implications (5): |
|
Definition
- Get pt off your floor if possible.
- Continuous heart monitoring
- No telemetry
- Crash cart by door.
- DONT look at labwork after giving as the serum level will remain high.
|
|
|
Term
Cardiotonic Agents:
Phosphodiesterase Inhibitors
Prototype:____ |
|
Definition
|
|
Term
Cardiotonic Agents:
Phosphodiesterase Inhibitors
Prototype: Inamrinone (Inocor)
Indications (2): |
|
Definition
- End stage HF pts who aren't responding to Dig, diuretics, or vasodilators.
- Given while admitted or schedule out pt clinic- Short term Tx.
|
|
|
Term
Cardiotonic Agents:
Phosphodiesterase Inhibitors
Prototype: Inamrinone (Inocor)
Action (1): |
|
Definition
- Increases Ca levels in cardiac cell results in stronger contractions, vasodilation
|
|
|
Term
Cardiotonic Agents:
Phosphodiesterase Inhibitors
Prototype: Inamrinone (Inocor)
Adverse Effects (3): |
|
Definition
- Hypotension
- Arrhythmias
- Buring @ IV site
|
|
|
Term
Cardiotonic Agents:
Phosphodiesterase Inhibitors
Prototype: Inamrinone (Inocor)
Nursing Implications |
|
Definition
- Telemetry
- s&s of hypotension must be initiated in CCU/ short stay, etc & then can be monitored on the floor.
- Gradually increase tapering, frequent VS when starting (q 15mins)
|
|
|